Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Permethrin Cream 5% vs Elimite in Active Scabies
NCT02978508Phase 3Completed
- Sponsor
- Mayne Pharma
- Start
- Nov 2016
- Primary completion
- May 2017
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of permethrin in scabies (2 arms), sponsored by Mayne Pharma. Primary endpoint: Proportion of Patients That Are Identified as Cured at Day 28. Started Nov 2016; status: completed.
02
Drugs
permethrin
03
Conditions
scabies
Beyond the preview
Go deeper on NCT02978508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02978508.